We received the acceptance of the final report of H2020 nTRACK project. The aim of the project was to label stem cells with nTRACK gold nanoparticles and inject them into an injured muscle and tracked using imaging systems. The project was coordinated by @LEITAT and Dr. Marc Masa.
For us, nTRACK has been the largest Horizon Europe project in which BIOEMTECH has participate and was definitely a catalyst in our growth. On the one hand it provided us valuable experience in the preclinical evaluation of nanoparticles and helped us develop the company, our laboratories and CRO services. On the other hand it gave us the opportunity to make new friends and work with excellent collaborators: Leitat Technological Center, Bar-Ilan University, Pluri (Pluristem), University Medical Center Mainz, MyBiotech GmbH, Vall d’Hebron Institute of Research (VHIR) – Vall d’Hebron Institut de Recerca, Vivotecnia, RIVM National Institute for Public Health and the environment, ASPHALION, Cambridge Nanomaterials Technology Ltd. We look forward to working with all of you again!
25 August 2022